Perioperative Chemotherapy in Muscle-Invasive Bladder Cancer to Enhance Survival and/or as a Strategy for Bladder Preservation

Seminars in Oncology

Volumn 34, Issue 2, 2007, Pages 122-128

  Sternberg, Cora N ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; TAXANE DERIVATIVE; VINBLASTINE; VINCRISTINE;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; HUMAN; META ANALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 33947200580     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2006.12.006     Document Type: Article

References (62)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Dalbagni G., Genega E., Hashibe M., et al. Cystectomy for bladder cancer: A contemporary series. J Urol 165 (2001) 1111-1116
3. Bassi P., Ferrante G.D., Piazza N., et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort. J Urol 161 (1999) 1494-1497
4. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
5. Sternberg C.N., Yagoda A., Scher H.I., et al. Preliminary results of methotrexate, vinblastine, Adriamycin and cisplatin (M-VAC) in advanced urothelial tumors. J Urol 133 (1985) 403-407
6. Sternberg C.N. Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer. In: Lerner S.P., Schoenberg M.P., and Sternberg C.N. (Eds). Textbook of Bladder Cancer (2006), Taylor & Francis, Abingdon, UK 657-664
7. Sternberg C.N. Current perspectives in muscle invasive bladder cancer. Eur J Cancer 38 (2002) 460-467
8. Sternberg C.N., Pansadoro V., Calabro F., et al. Can patient selection for bladder preservation be based on response to chemotherapy?. Cancer 97 (2003) 1644-1652
9. Herr H.W., and Scher H.I. Surgery of invasive bladder cancer: Is pathologic staging necessary?. Semin Oncol 17 (1990) 590-597
10. Frazier H.A., Robertson J.E., Dodge R.K., et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71 (1993) 3993-4001
11. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 15 (1994) 31-35
12. Stein J.P. Indications for early cystectomy. Semin Urol Oncol 18 (2000) 289-295
13. Sanchez-Ortiz R.F., Huang W.C., Mick R., et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169 (2003) 110-115
14. Stein J.P. Contemporary concepts of radical cystectomy and the treatment of bladder cancer. J Urol 169 (2003) 116-117
15. Millikan R., Dinney C., Swanson D., et al. Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005-4013
16. Hall M.C., Swanson D.A., and Dinney C.P. Complications of radical cystectomy: Impact of the timing of perioperative chemotherapy. Urology 47 (1996) 826-830
17. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
18. Grossman H.B., Natale R.B., Tangen C.M., et al. Errata Corrige for: "Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer" published in N Engl J Med. 2003 Aug 28;349(9):859-66. N Engl J Med 349 (2003) 1880
19. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet 354 (1999) 533-540
20. Hall R.R., and International Collaboration of Trialists of the MRC Advanced Bladder Cancer Group. Updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. J Clin Oncol 21 (2002) 178a (abstr 710)
21. Bassi P., Pagano F., Pappagallo G., et al. Neoadjuvant M-VAC of invasive bladder cancer: The G.U.O.N.E. multicenter phase III trial. Eur Urol 33 (1998) 142 (suppl 1, abstr)
22. Malmstrom P.U., Rintala E., Wahlqvist R., et al. Five year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy. J Urol 155 (1996) 1903-1906
23. Sherif A., Rintala E., Mestad O., et al. Neoadjuvant cisplatin-methotrexate chemotherapy of invasive bladder cancer-Nordic cystectomy trial 2. Scand J Urol Nephrol 36 (2002) 419-425
24. Wallace D.M., Raghavan D., Kelly K.A., et al. Neoadjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67 (1991) 608-615
25. Coppin C.M., Gospodarowicz M.K., James K., et al., The National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
26. Martinez Pineiro J.A., Gonzalez Martin M., and Arocena F. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: Prospective randomized phase III study. J Urol 153 (1995) 964-973
27. Natale R.B., Grossman H.B., Blumenstein B., et al. SWOG 8710 (INT-0080): Randomized phase III trial of neoadjuvant M-VAC and cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. Proc Am Soc Clin Oncol 20 (2001) 2a (abstr)
28. GISTV (Italian Bladder Cancer Study Group). Neoadjuvant treatment for locally advanced bladder cancer: A randomized prospective clinical trial. J Chemother 8 (1996) 345-346
29. Orsatti M., Curotto A., and Canobbio L. Alternating chemo-radiotherapy in bladder cancer: A conservative approach. Int J Radiat Oncol Biol Phys 33 (1995) 173-178
30. Abol-Enein H., El Makresh M., El Baz M., et al. Neoadjuvant chemotherapy in treatment of invasive transitional bladder cancer: A controlled, prospective randomised study. Br J Urol 80 suppl 2 (1997) 49
31. Sylvester R.J., and Yamaguchi T. Clinical trial design. In: Lerner S.P., Schoenberg M.P., and Sternberg C.N. (Eds). Textbook of Bladder Cancer (2006), Taylor & Francis, Abingdon, UK 647-655
32. Sternberg C.N., and Parmar M.K.B. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle invasive bladder cancer. J Clin Oncol 19 suppl 1 (2001) 21S-26S
33. Winquist E., Kirchner T.S., Segal R., et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis. Genitourinary Cancer Disease Site Group, Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative. J Urol 171 (2004) 561-569
34. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48 (2005) 202-205
35. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48 (2005) 189-199
36. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 (2003) 1927-1934
37. Sherif A., Holmberg L., Rintala E., et al., Nordic Urothelial Cancer Group. Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: A combined analysis of two Nordic studies. Eur Urol 45 (2004) 297-303
38. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol 22 (2004) 2781-2789
39. Droz J.P. Editorial comment on "Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration". Eur Urol 48 (2005) 205-206
40. Solsona E. Radical TURBT. In: Lerner S.P., Schoenberg M.P., and Sternberg C.N. (Eds). Textbook of Bladder Cancer (2006), Taylor & Francis, Abingdon, UK 535-541
41. Hautmann R.E. Urinary diversion: Ileal conduit to neobladder. J Urol 169 (2003) 834-842
42. Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19 (2001) 89-93
43. Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: Long-term followup of a prospective study. J Urol 159 (1998) 95-99
44. Schultz P.K., Herr H.W., and Zhang Z. Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients with M-VAC with 5 years follow-up. J Clin Oncol 12 (1994) 1394-1401
45. Herr H.W., and Scher H.I. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12 (1994) 975-980
46. Sternberg C.N. Chemotherapy for local treatment of bladder cancer. Semin Radiat Oncol 15 (2005) 60-65
47. Herr H.W. Uncertainty and outcome of invasive bladder tumors. Urol Oncol 2 (1996) 92-95
48. Herr H.W., Bajorin D.F., and Scher H.I. Neoadjuvant chemotherapy and bladder sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol 16 (1998) 1298-1301
49. Chang S.S., Hassan J.M., Cookson M.S., et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170 (2003) 1085-1087
50. Skinner D.G., Daniels J.R., Russell C.A., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 145 (1991) 459-467
51. Stockle M., Meyenburg W., Wellek S., et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 nad pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy results of a controlled prospective study. J Urol 148 (1992) 302-307
52. Stockle M., Meyenburg W., and Wellek S. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long term results of a controlled prospective study and further clinical experience. J Urol 153 (1995) 47-52
53. Lehmann J., Franzaring L., Thuroff J., et al. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. Br J Urol Int 97 (2006) 42-47
54. Otto T., Börgemann C., Krege S., et al. Adjuvant chemotherapy in locally advanced bladder cancer (PT3/PN1-2,M0)-A phase III study. Eur Urol 39 (2001) 147 (suppl 5, abstr)
55. Sylvester R., and Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why. Ann Oncol 11 (2000) 851-856
56. Jin J.O., Boyar M., Petrylak D.P., et al. Adjuvant chemotherapy for invasive bladder cancer. In: Lerner S.P., Schoenberg M.P., and Sternberg C.N. (Eds). Textbook of Bladder Cancer (2006), Taylor & Francis, Abingdon, UK 665-670
57. Dreicer R., Manola J., Roth B.J., et al. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium. Cancer 100 (2004) 1639-1645
58. Sternberg C.N., and Cote R. p53 Alterations in bladder cancer. J Eur Urol (2005) 12-13 Dec
59. Logothetis C.J., Johnson D.E., Chong C., et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: An update. J Clin Oncol 6 (1988) 1590-1596
60. Studer U.E., Bacchi M., Biedermann C., et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol 152 (1994) 81-84
61. Bono A.V., Benvenuti C., Gibba A., et al. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study. Acta Urol Ital 11 (1997) 5-8
62. Freiha F., Reese J., and Torti F.M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine, and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155 (1996) 495-499